CMMB
Price
$1.30
Change
+$0.05 (+4.00%)
Updated
Mar 10 closing price
Capitalization
23.57M
58 days until earnings call
DTIL
Price
$5.10
Change
-$0.08 (-1.54%)
Updated
Mar 10 closing price
Capitalization
39.74M
Ad is loading...

CMMB vs DTIL

Header iconCMMB vs DTIL Comparison
Open Charts CMMB vs DTILBanner chart's image
Chemomab Therapeutics
Price$1.30
Change+$0.05 (+4.00%)
Volume$71.53K
Capitalization23.57M
Precision BioSciences
Price$5.10
Change-$0.08 (-1.54%)
Volume$65.44K
Capitalization39.74M
CMMB vs DTIL Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. DTIL commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and DTIL is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CMMB: $1.30 vs. DTIL: $5.10)
Brand notoriety: CMMB and DTIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 15% vs. DTIL: 10%
Market capitalization -- CMMB: $23.57M vs. DTIL: $39.74M
CMMB [@Biotechnology] is valued at $23.57M. DTIL’s [@Biotechnology] market capitalization is $39.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileDTIL’s FA Score has 0 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • DTIL’s FA Score: 0 green, 5 red.
According to our system of comparison, DTIL is a better buy in the long-term than CMMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 4 TA indicator(s) are bullish while DTIL’s TA Score has 5 bullish TA indicator(s).

  • CMMB’s TA Score: 4 bullish, 5 bearish.
  • DTIL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а -13.91% price change this week, while DTIL (@Biotechnology) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -8.82%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

CMMB is expected to report earnings on May 08, 2025.

DTIL is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DTIL($39.7M) has a higher market cap than CMMB($23.6M). DTIL YTD gains are higher at: 33.858 vs. CMMB (-28.177). DTIL has higher annual earnings (EBITDA): 18.8M vs. CMMB (-15.37M). DTIL has more cash in the bank: 101M vs. CMMB (19.4M). CMMB has less debt than DTIL: CMMB (342K) vs DTIL (30.3M). DTIL has higher revenues than CMMB: DTIL (75.1M) vs CMMB (0).
CMMBDTILCMMB / DTIL
Capitalization23.6M39.7M59%
EBITDA-15.37M18.8M-82%
Gain YTD-28.17733.858-83%
P/E RatioN/A12.86-
Revenue075.1M-
Total Cash19.4M101M19%
Total Debt342K30.3M1%
FUNDAMENTALS RATINGS
CMMB vs DTIL: Fundamental Ratings
CMMB
DTIL
OUTLOOK RATING
1..100
5011
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
50
Fair valued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
9646
PRICE GROWTH RATING
1..100
9090
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
22n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMMB's Valuation (32) in the Biotechnology industry is in the same range as DTIL (50). This means that CMMB’s stock grew similarly to DTIL’s over the last 12 months.

CMMB's Profit vs Risk Rating (99) in the Biotechnology industry is in the same range as DTIL (100). This means that CMMB’s stock grew similarly to DTIL’s over the last 12 months.

DTIL's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for CMMB (96). This means that DTIL’s stock grew somewhat faster than CMMB’s over the last 12 months.

DTIL's Price Growth Rating (90) in the Biotechnology industry is in the same range as CMMB (90). This means that DTIL’s stock grew similarly to CMMB’s over the last 12 months.

DTIL's P/E Growth Rating (97) in the Biotechnology industry is in the same range as CMMB (100). This means that DTIL’s stock grew similarly to CMMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMMBDTIL
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DFH25.940.57
+2.25%
Dream Finders Homes
XEL69.351.35
+1.99%
Xcel Energy
CARA4.91-0.01
-0.20%
Cara Therapeutics Inc
NNBR2.69-0.02
-0.92%
NN
ELVN20.27-0.73
-3.48%
Enliven Therapeutics

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
+4.00%
AXON - CMMB
37%
Loosely correlated
-2.08%
SPRB - CMMB
36%
Loosely correlated
-2.32%
SYRE - CMMB
30%
Poorly correlated
-4.21%
OVID - CMMB
30%
Poorly correlated
-5.76%
DSGN - CMMB
30%
Poorly correlated
-0.71%
More

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-1.54%
AXON - DTIL
46%
Loosely correlated
-2.08%
ORMP - DTIL
41%
Loosely correlated
-1.95%
ARRY - DTIL
39%
Loosely correlated
+3.74%
RENB - DTIL
36%
Loosely correlated
+4.56%
COGT - DTIL
35%
Loosely correlated
-2.00%
More